Orthotic Products Management Contracts Addressed In IG Advisory Opinion
This article was originally published in The Gray Sheet
Executive Summary
A marketing and billing arrangement between a manufacturer of orthotics and other orthopedic "soft" goods ["Company A"] and a marketing consulting/medical billing firm ["Company B"] likely would run afoul of Medicare anti-kickback provisions, HHS Office of the Inspector General Chief Counsel McCarty Thornton concludes in a March 25 advisory opinion.